C12Y 114/13098
Cholesterol 24-hydroxylase
Official title: Cholesterol 24-hydroxylase (1.14.13.98)
C12Y114/13098 (Cholesterol 24-hydroxylase) appears on 2 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 4
- Assignees
- 8
- Inventors
- 12
- Latest grant
- 12 Nov 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 1 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 1 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Expression vector for cholesterol 24-hydrolase in therapy of polyglutamine repeat spinocerebellar ataxias20 Mar 2025US 2025/0090641 A1Brainvectis
- Methods for treating neurological disease16 Nov 2023US 2023/0365963 A1Asklepios Biopharmaceutical, Inc.
- Expression vector for cholesterol 24-hydrolase in therapy of polyglutamine repeat spinocerebellar ataxias14 Nov 2019US 2019/0343927 A1Brainvectis
- Use of the CYP46A1 Gene for the Treatment of Alzheimer's Disease10 Feb 2011US 2011/0034540 A1Institut National De La Sante Et De La Recherche Medicale (Inserm)
Most cited
By later US patents